Hidradenitis suppurativa (HS) is a chronic inflammatory
skin disease of the hair follicles leading to painful lesions, associated with increased levels of pro-inflammatory
cytokines. Numerous guidelines recommend
antibiotics like
clindamycin and
rifampicin in combination, as first-line systemic
therapy in moderate-to-severe forms of
inflammation. HS has been proposed to be mainly an auto-inflammatory disease associated with but not initially provoked by bacteria. Therefore, it has to be assumed that the pro-inflammatory milieu previously observed in HS skin is not solely dampened by the bacteriostatic inhibition of
DNA-dependent
RNA polymerase. To further clarify the mechanism of anti-inflammatory effects of
rifampicin, ex vivo explants of lesional HS from 8 HS patients were treated with
rifampicin, and its effect on
cytokine production, immune cells as well as the expression of
Toll-like receptor 2 (TLR2) were investigated. Analysis of cell culture medium of
rifampicin-treated HS explants revealed an anti-inflammatory effect of
rifampicin that significantly inhibiting
interleukin (IL)-1β,
IL-6,
IL-8,
IL-10 and tumour
necrosis factor (TNF)-α production. Immunohistochemistry of the
rifampicin-treated explants suggested a tendency for it to reduce the expression of TLR2 while not affecting the number of immune cells.